Site Map Svenska
Home About BioPhausia Products Financial information Contact Us
Press Releases Reports

 

Archive 2008
Archive 2007
Archive 2006
2008-08-06Financial goals for BioPhausia
2008-08-04BioPhausia's extraordinary shareholders' meeting approved the rights issue 2:1 at an issue price of SEK 1.35 per share
2008-07-31Exchange ratio and subscription price set for the rights issue in BioPhausia – 2:1 and SEK 1.35 Respectively
2008-07-01Notice of Extraordinary general meeting in BioPhausia AB (publ), August 4, 2008
2008-07-01Rights issue in BioPhausia AB to finance the acquisition of the pharmaceutical products portfolio acquired from AstraZeneca AB
2008-06-30BioPhausia completes the acquisition of a pharmaceutical product portfolio from AstraZeneca AB
2008-05-26BioPhausia acquires pharmaceutical portfolio from AstraZeneca
2008-04-08Notice of the 2008 annual general meeting

BioPhausia AB Blasieholmsgatan 2, SE-111 48 Stockholm, Sweden
Telephone: +46 (0)8-407 64 30, Fax: +46 (0)8-407 64 39, E-mail: info@biophausia.se